Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Lim

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Scientific Reports|February 18, 2021
Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancerBella Nguyen, Nicholas C Wong, Tim Semple, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid CarcinomaAnnette M Lim, Graham R Taylor, Andrew Fellowes, et al.
Oral Oncology|November 22, 2025
Evaluating CD103<sup>+</sup> intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal CancerChia Yuen Chong, Richard J Young, Annette M Lim, et al.
Head & Neck|October 14, 2015
Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinomaDamien Urban, June Corry, Ben Solomon, et al.
Cancers|April 27, 2024
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint InhibitorsLuke S McLean, Annette M Lim, Christopher Angel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trialAnnette M Lim, Danny Rischin, Richard Fisher, et al.
Asia-Pacific Journal of Clinical Oncology|June 26, 2024
Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012-2022Nadia Hitchen, Adel Shahnam, Sathya Manoharan, et al.
Oral Oncology|January 23, 2024
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancerRichard J Young, Christopher Angel, Mathias Bressel, et al.
Scientific Reports|April 10, 2020
A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinomaBella Nguyen, Katie Meehan, Michelle R Pereira, et al.
Cancer Medicine|May 9, 2020
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing diseaseKatie Meehan, Connull Leslie, Michaela Lucas, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Scientific Reports|February 18, 2021
Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancerBella Nguyen, Nicholas C Wong, Tim Semple, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2016
BRAF Inhibition in BRAFV600E-Positive Anaplastic Thyroid CarcinomaAnnette M Lim, Graham R Taylor, Andrew Fellowes, et al.
Oral Oncology|November 22, 2025
Evaluating CD103<sup>+</sup> intratumoral immune cell abundance and PD-L1 CPS in primary tumors versus lymph nodes in Human papillomavirus associated oropharyngeal CancerChia Yuen Chong, Richard J Young, Annette M Lim, et al.
Head & Neck|October 14, 2015
Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus-positive oropharyngeal squamous cell carcinomaDamien Urban, June Corry, Ben Solomon, et al.
Cancers|April 27, 2024
A Retrospective Review and Comprehensive Tumour Profiling of Advanced Non-Melanomatous Cutaneous Spindle Cell Neoplasms Treated with Immune-Checkpoint InhibitorsLuke S McLean, Annette M Lim, Christopher Angel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trialAnnette M Lim, Danny Rischin, Richard Fisher, et al.
Asia-Pacific Journal of Clinical Oncology|June 26, 2024
Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012-2022Nadia Hitchen, Adel Shahnam, Sathya Manoharan, et al.
Oral Oncology|January 23, 2024
Characterising B cell expression and prognostic significance in human papillomavirus positive oropharyngeal cancerRichard J Young, Christopher Angel, Mathias Bressel, et al.
Scientific Reports|April 10, 2020
A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinomaBella Nguyen, Katie Meehan, Michelle R Pereira, et al.
Cancer Medicine|May 9, 2020
Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing diseaseKatie Meehan, Connull Leslie, Michaela Lucas, et al.
Pageof 5